- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Hong Kong Pharmaceuticals & Biotech Upcoming Dividends
Results
4
Companies which have announced upcoming dividend payments.
4 companies
Essex Bio-Technology
Market Cap: HK$1.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$2.35
7D
0%
1Y
-58.6%
Jacobson Pharma
Market Cap: HK$2.1b
Through its subsidiaries, engages in the development, production, marketing, and sale of essential medicines and specialty drugs in Hong Kong, Mainland China, Macau, and internationally.
2633
HK$1.05
7D
0.5%
1Y
-29.5%
JBM (Healthcare)
Market Cap: HK$1.6b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, Singapore, and internationally.
2161
HK$1.91
7D
2.1%
1Y
-37.2%
Sino Biopharmaceutical
Market Cap: HK$99.6b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$5.60
7D
17.2%
1Y
-31.5%